Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Core One Labs Inc C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (CSE:COOL)

Canadian Investment Regulatory Organization Trading Halt - COOL

Canada NewsWire August 6, 2024

Core One Enters into Loan Agreement with Right Season Investments

Accesswire July 8, 2024

Core One Labs Inc. Announces Initial Agreement for Potential Sale of Proprietary Biosynthetic Psilocybin, Facilitating Entry into the International Market

Accesswire December 8, 2023

Core One Labs' Akome Reveals Impressive Results for its Psychedelic Bio-Compounds Designed to Target Alzheimer's and Parkinson's, Showing Potential to Outperform Current Treatment Methods

Accesswire December 1, 2023

Core One's Akome Reveals Groundbreaking Positive Results from its Second Round of Stage 1 Animal Model Studies for Bio-Compounds Targeting Alzheimer's and Parkinson's Disease

Accesswire August 4, 2023

Core One Labs', Awakened Biosciences, Announces Groundbreaking Step Forward in Isolating and Purifying Psilocybin from Mushroom Biomass

Accesswire August 1, 2023

Core One's Akome Receives Positive Preliminary Stage 1 Animal Model Study Results for Bio-Compound Targeting Alzheimer's and Parkinson's Disease

Accesswire July 28, 2023

Core One Labs Enters into Letter of Intent for First Sale of Its Psychedelic Compounds

Accesswire July 21, 2023

Core One's Vocan Biotechnologies Incorporates New Bioreactor Equipment into Production Process Significantly Increasing Throughput of Proprietary Biosynthetic Psilocybin

Accesswire July 11, 2023

Bullboard Posts (CSE:COOL)

RE:RE:What is next

So basically, 0 + 0 still equals 0.
CancerSlayer - November 5, 2024

RE:What is next

Monthly report... https://webfiles.thecse.com/COOL-2024-10-F7.pdf?CTDh0ETYNjmw2l0RGI2FbiJlo7BIENay
lscfa - November 5, 2024

What is next

Does anybody know what is going on? I haven't seen a offical delisting yet. Is there a furture for this? 
helpline88 - November 4, 2024

RE:RE:RE:RE:RE:Suspension

Thank you for your comments CancerSlayer. I can't say that I have read unequivocally that the patents reached true protection. But...
helpline88 - September 13, 2024

RE:RE:RE:RE:Suspension

Fortunately, I've been out of this dog for a while, but is Core's tech even patented?  Correct me if I'm wrong, but it...
CancerSlayer - September 12, 2024

RE:RE:RE:Suspension

No news from the company as to what is going on. My guess is this will eventually be delisted and Right Season Investments will end up...
helpline88 - September 10, 2024